Explore

Trendline Trendline
Faruqi Faruqi, LLP Alerts ImmunityBio Investors of Class Action Deadline

Faruqi Faruqi, LLP Alerts ImmunityBio Investors of Class Action Deadline

Faruqi Faruqi, LLP Alerts ImmunityBio Investors of Class Action Deadline
Trendline Trendline
ImmunityBio Faces Securities Class Action Over Misleading Statements

ImmunityBio Faces Securities Class Action Over Misleading Statements

ImmunityBio Faces Securities Class Action Over Misleading Statements
Trendline Trendline
Gossamer Bio Faces Securities Class Action After Trial Failure

Gossamer Bio Faces Securities Class Action After Trial Failure

Gossamer Bio Faces Securities Class Action After Trial Failure
Trendline Trendline
Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Causes Stock Plunge

Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Causes Stock Plunge

Gossamer Bio Faces Securities Class Action After Phase 3 Trial Failure Causes Stock Plunge
Trendline Trendline
Gossamer Bio Faces Securities Class Action Following 80% Stock Drop Due to Trial Failure

Gossamer Bio Faces Securities Class Action Following 80% Stock Drop Due to Trial Failure

Gossamer Bio Faces Securities Class Action Following 80% Stock Drop Due to Trial Failure
Trendline Trendline
Gossamer Bio Faces Securities Class Action Following 80% Stock Drop After Trial Failure

Gossamer Bio Faces Securities Class Action Following 80% Stock Drop After Trial Failure

Gossamer Bio Faces Securities Class Action Following 80% Stock Drop After Trial Failure
Trendline Trendline
Faruqi Faruqi Reminds Gossamer Bio Investors of Class Action Deadline

Faruqi Faruqi Reminds Gossamer Bio Investors of Class Action Deadline

Faruqi Faruqi Reminds Gossamer Bio Investors of Class Action Deadline
Trendline Trendline
Immutep Faces Securities Class Action as Trial Discontinuation Impacts Investors

Immutep Faces Securities Class Action as Trial Discontinuation Impacts Investors

Immutep Faces Securities Class Action as Trial Discontinuation Impacts Investors
Trendline Trendline
Faruqi Faruqi, LLP Reminds Medpace Investors of Class Action Deadline Amid Allegations of Misleading Statements

Faruqi Faruqi, LLP Reminds Medpace Investors of Class Action Deadline Amid Allegations of Misleading Statements

Faruqi Faruqi, LLP Reminds Medpace Investors of Class Action Deadline Amid Allegations of Misleading Statements
Trendline Trendline
Rosen Law Firm Alerts Aldeyra Therapeutics Investors to Securities Fraud Lawsuit Deadline

Rosen Law Firm Alerts Aldeyra Therapeutics Investors to Securities Fraud Lawsuit Deadline

Rosen Law Firm Alerts Aldeyra Therapeutics Investors to Securities Fraud Lawsuit Deadline
Trendline Trendline
Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline

Rosen Law Firm Urges Gossamer Bio Investors to Act Before Class Action Deadline
Trendline Trendline
Rosen Law Firm Calls on Globant Investors to Join Class Action Lawsuit

Rosen Law Firm Calls on Globant Investors to Join Class Action Lawsuit

Rosen Law Firm Calls on Globant Investors to Join Class Action Lawsuit